Geigle, Peter (CMBlu Energy 202310 CEO + Founder) |
Chief Executive Officer (CEO) |
CMBlu Energy (Group) |
Germany |
Geissler, Holger (ipOcean Global GmbH 202004 Managing Director) |
Managing Director |
ipOcean Global GmbH |
Germany |
Gelber, Jeremy (Pamplona Capital 201706 Partner) |
Chief Executive Officer (CEO) |
Parexel (Group) |
United States (USA) |
Gelbke, Franz (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
Geller, Matthew (Geller Biopharm 2008– Managing Director + Founder before Rodman + Renshaw) |
Managing Director |
Geller Biopharm Inc. |
United States (USA) |
Geller, Patricia (Qiagen 2009 Director Corporate Strategy) |
Corporate Strategy Manager |
Qiagen (Group) |
Germany |
Gelone, Steven (Nabriva 20707– promoted COO joined 201412 before Spark Therapeutics + ViroPharma) |
Chief Operating Officer (COO) |
Nabriva (Group) |
Austria |
Genge, Sandra (Endress+Hauser 202302 existent Supervisory Board Member representing Endress family) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
Gent, Ricardo (DIB 200503 Managing Director) |
Managing Director |
VCI (Verband der Chemischen Industrie e. V.) |
Germany |
Genth, Peter |
n. a. |
FIZ Technik (Group) |
Germany |
Gentz, Torben (Helmholtz 200908 Alfred Wegener Institute) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Geoghegan-Quinn, Máire (EU (govt) 201103 Commissioner for Research, Innovation and Science) |
Administrative Officer (personnel) |
EU (govt) |
Belgium |
George, Jeff (Novartis 201404– Divison Head of Alcon before Division Head of Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
George, Martine (GPC Biotech 200604– Senior VP + CMO) |
Chief Medical Officer (CMO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
George, Peter (Clinigen Group 201303 CEO) |
Chief Executive Officer (CEO) |
Clinigen (Group) |
United Kingdom (GB) |
George, Simeon (GSK 201504 SR One) |
Investment Manager |
SR One (Group) |
United States (USA) |
George, Tad (RareCyte 202006 SVP of Biology RnD) |
Research & Development Manager |
RareCyte Inc. |
United States (USA) |
Georgieva, Svetoslava (EU (govt) 202309 Board Chair of EIC Fund) |
Board member |
EU (govt) |
EU (European Union) |
Geraghty, Deborah (Anokion 202210 CEO) |
Chief Executive Officer (CEO) |
Anokion (Group) |
Switzerland |
Gerber, Fritz (200808 before Roche CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
Gerdes, Friedericke (Epigenomics 200811– Head Marketing before Agendia) |
Sales Manager / Marketing Manager |
Epigenomics (Group) |
Germany |
Gerhardt, Geoff (Scitara 202103 CTO before Waters 201809 Senior Director Corporate Development) |
Chief Technology/Technical Officer (CTO) |
Scitara Coproration |
United States (USA) |
Gericke, Dieter (Homburger 201512 Partner Corporate & M&A) |
Attorney / Lawyer |
Homburger AG |
Switzerland |
Gericke, Germo (Ariceum Therapeutics 202302– CMO before Novartis AAA joined Novartis in 2001 from McKinsey) |
Chief Medical Officer (CMO) |
Ariceum Therapeutics (Group) |
Switzerland |
Gerin, Sébastian (Cytel 201710 SVP Strategy + Performance) |
Business Development Manager / Strategy Manager |
Cytel (Group) |
United States (USA) |
Gerlach, Ernst (NRW.Bank 200607 CEO) |
Chief Executive Officer (CEO) |
Nordrhein-Westfalen (govt region) |
Germany |
Gerlach, Herwig (Klinikum Neukölln Berlin 200606 Prof) |
Professor |
Humboldt University Berlin |
Germany |
Gerlich, Dieter (Univ Chemnitz 1993–2009 Professor RETIRED 2009) |
Professor |
Technical University Chemnitz (TU Chemnitz) |
Germany |
Gerlinger, Tobias (Humatrix 201111 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
Gerlinghaus, Fabian (Cellares 201904– CEO + Co-Founder before Synthego Corp + Festo) |
Chief Executive Officer (CEO) |
Cellares Corporation |
United States (USA) |
Germa, Caroline (Transcenta 202311 CMO + Board Member at Ymmunobio before AstraZeneca) |
Chief Medical Officer (CMO) |
Transcenta |
|
Germa, Christian P. (Ymmunobio 202311 CFO) |
Chief Financial Officer (CFO) |
Ymmunobio AG |
Switzerland |
German, Jill (Roche 202110 Head of Roche Diagnostics Pathology Customer Area) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
Germeroth, Lothar (IBA GmbH 201001 Managing Director + Stage Cell Therapeutics 200909– Managing Director COO) |
Managing Director |
IBA GmbH (Group) |
Germany |
Germonpré, David (Adrenomed 202207– CFO before MTIP + Gemma Frisius Fund + Advisor to Govt of Flandes + Dexia Bank) |
Chief Financial Officer (CFO) |
Adrenomed AG |
Germany |
Gerndt, Carsten (acphis 201011 Managing Director) |
Managing Director |
acphis GmbH & Co. KG |
Germany |
Gerndt-Nijaka, Agnieszka (acphis 201011 Managing Director) |
Managing Director |
acphis GmbH & Co. KG |
Germany |
Gerngross, Tillman (Adimab 200803 CEO + Co-founder + Arsanis Co-founder) |
Chief Executive Officer (CEO) |
Adimab Inc. |
United States (USA) |
Gersel Pedersen, Anders (Lundbeck 2000–201812 Head RnD RETIRED 12/18) |
Research & Development Manager |
Lundbeck (Group) |
Denmark |
Gersting, Søren W. (Inivua 202406 Managing Director + Co-Founder) |
Managing Director |
Iniuva GmbH |
Germany |
Gerstner, Jutta (Nynomic 202005 Senior Sales Manager at LemnaTec) |
Sales Manager / Marketing Manager |
Nynomic (Group) |
Germany |
Gerstner, Norman (Molecular Diagnostics Group 202212 CEO of Biotype GmbH) |
Chief Executive Officer (CEO) |
Molecular Diagnostics Group (MDG, family of Wilhelm Zörgiebel) (Group) |
Germany |
Gertenbach, Laura (Innocent Meat 202403 CEO + Founder) |
Chief Executive Officer (CEO) |
Innocent Meat GmbH |
Germany |
Gerth, André (BioPlanta 201106 Managing Director) |
Managing Director |
Vita 34 (Group) |
Germany |
Gerth, Ulrich (Isar Bioscience GmbH 201801 Managing Director) |
Managing Director |
Isar Bioscience GmbH |
Germany |
Gertis, Robert |
n. a. |
Affimed (Group) |
Germany |
Gertsch, Martin (Santhera 201501 Non-executive Chairman of the Board) |
Board member, non-executive |
Santhera (Group) |
Switzerland |
Gerwert, Klaus (Univ Bochum 201211 Professor plus 202301 Managing Director + Founder of BetaSense) |
Professor |
University of Bochum (Ruhr-Universität Bochum, RUB) |
Germany |
Geschwill, Klaus (Osthus 201508 VP Customer Relationship) |
Sales Manager / Marketing Manager |
Osthus (Group) |
Germany |
Gessner, Regine (EJ Krause 201108 Director Sales + Marketing at EJ Krause Germany) |
Sales Manager / Marketing Manager |
E.J. Krause (EJK) (Group) |
Germany |
Geulen, Julia (GIT Verlag 200502) |
n. a. |
Wiley (Group) |
Germany |
Gewert, Jan-Arne (Oncotec Pharma Produktion GmbH 201309 Managing Director) |
Managing Director |
Klocke (Group) |
Germany |
Gewiese, Bernd (Bruker 201003 President Bruker BioSpin) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Gewinner, Irina (IPM AG 202311 Project Manager Conferences + Events) |
Event Manager / Conference Manager |
IPM AG – Institut für Produktionsmanagement |
Germany |
Geyer, Matthias (Univ Bonn 201610 Prof + Dept Head for Structural Immunology + Co-Founder of IFM Therapeutics) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
Geyer, Philipp E. (ions.bio 202408– Managing Director + Co-Founder before OmicEra Diagnostics) |
Managing Director |
ions.bio GmbH |
Germany |
Ghabache, Jean (Partners Group 202407 Manager at Private Equity Health + Life Europe) |
Investment Manager |
Partners Group (Group) |
Switzerland |
Ghasparian, Arin (Shape Biopharmaceuticals 202411 CEO + Founder before Virometix CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Shape Biopharmaceuticals (Group) |
United States (USA) |
Gheorghe, Andreea (Celonic 202110 Digital Marketing Lead) |
Sales Manager / Marketing Manager |
Celonic (Group) |
Switzerland |
Gheorghiu, Vlad-Cristian (Kyan Health 202411 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Kyan Health (Group) |
Switzerland |
Ghobarah, Adam (Top Harvest Capital 202209 Founder before Google + Google Ventures) |
Company Founder |
Top Harvest Capital (Adam Ghobarah) |
|
Ghose, Chandrabali (Bioharmony Therapeutics 201901 CEO + Founder) |
Chief Executive Officer (CEO) |
Bioharmony Therapeutics Inc. |
United States (USA) |
Ghosh, Dipankar (Thermo Fisher 201506 Director Marketing Life Science MS) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
Ghosh, Kunal (Inscopix 202211 CEO + Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
|
Ghostine, Gilbert (Firmenich 202205 CEO) |
Chief Executive Officer (CEO) |
Firmenich (Group) |
Switzerland |
Giambattista, Brian (PerkinElmer 200810 president digital imaging) |
Product Manager (personnel) |
PerkinElmer (Group) |
United States (USA) |
Gianneschi, Nathan C. (Univ California 201506 Dept of Chemistry + Biochemistry at UCSD) |
Researcher (university / research institute) |
University of California (System) |
United States (USA) |
Giardina, Giuseppe (Nikem Research 201201) |
n. a. |
Nikem Research S.r.l. |
Italy |
Gibbons, Winton (Numares 202006– President Numares Group Corp before Agena Bioscience + Siloam Biosciences + Nanosphere) |
President/Director/Head Business Group/Unit/Division |
Numares (Group) |
United States (USA) |
Gibbs, Krystle (Ten Bridge Communications 201703) |
Public Relations Manager / Investor Relations Manager |
Ten Bridge Communications (US) |
United States (USA) |
Gibson-Brade, Emma (Peak Scientific 201304– Market Researcher) |
market research |
Peak Scientific (Group) |
United Kingdom (GB) |
Giegerich, Robert |
n. a. |
University of Bielefeld |
Germany |
Giegold, Astrid (Max Planck Innovation 200610 Start-up Manager) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Giehring, Sebastian Carsten (Paia Biotech GmbH 201410– Managing Director + Founder) |
Managing Director |
Paia Biotech GmbH |
Germany |
Giersiefen, Helmut (Curacyte 200808 CEO) |
Chief Executive Officer (CEO) |
Curacyte (Group) |
Germany |
Gies, Otto H. (3B Scientifc) |
n. a. |
|
|
Giese, Armin (Modag 201909 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Modag GmbH |
Germany |
Giese, Klaus (Pantherna Therapeutics 201907 CEO) |
Chief Executive Officer (CEO) |
Pantherna Therapeutics GmbH |
Germany |
Gieseler, Carsten (Fodjan GmbH 201409 Managing Director + Co-founder) |
Managing Director |
Fodjan GmbH |
Germany |
Gieseler-von der Crone, Robert (Rodos BioTarget 201105 Managing Director) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Rodos BioTarget GmbH |
Germany |
Gieselmann, Volkmar (Univ Bonn 201101 Professor + Director IBMB) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
Gigova, Andriana (GATC Biotech 201611 Marketing Communications Project Manager) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
Gil Chavez, G. Joana (LignoPure 201910– Managing Director + Co-Founder) |
Managing Director |
Lignopure GmbH |
Germany |
Gil-Ad, Haim (NovellusDx 201804 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
NovellusDx Ltd. |
Israel |
Gilani, Saad (Yorkville Group 201308 Head of Healthcare Group at Yorkville Advisors) |
Investment Manager |
Yorkville Group (Group) |
United States (USA) |
Gilardi, John (Qiagen 201211 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Qiagen (Group) |
Germany |
Gilbert, Dennis (Applied Biosystems 200610 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Thermo Fisher (Group) |
Germany |
Gilbert, Richard (Fibrocor Therapetuics 202001 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Fibrocor Therapeutics Inc. |
Canada |
Gilbert, Walter (Biogen 199811 Founder) |
Company Founder |
Biogen (Group) |
United States (USA) |
Gildehaus, Nina (Qiagen 200802 Assoc Global Product Manager Plasmid DNA Purification) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
Gilgen, Lukas (Novartis 202406– CFO of MorphoSys before Novartis International AG) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Germany |
Gilham, Ian D. (Axis-Shield 200801 CEO– before COO) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United Kingdom (GB) |
Gilka-Bötzow, Bertram (S-Refit 201107) |
Investment Manager |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
Gillandt, Hartmut (SiChem GmbH 2001–200902– Managing Director) |
Managing Director |
Sirius Fine Chemicals SiChem GmbH |
Germany |
Gillessen, Dieter (Arpida 200505 Senior VP + COO) |
Chief Operating Officer (COO) |
Lallemand (Group) |
Switzerland |
Gilleßen, Bernhard (Helmholtz 201112 Projektträger Jülich) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Gilman, David (ADC Therapeutics 202206– Chief Business + Strategy Officer before ClearView Healthcare Partners) |
Business Development Manager / Strategy Manager |
ADC Therapeutics (Group) |
Switzerland |
Gilman, Michael (Arrakis Therapeutics 201702– CEO before Padlock Therapeutics 201501 CEO) |
Chief Executive Officer (CEO) |
Arrakis Therapeutics Inc. |
United States (USA) |
Gilsdorf, Chantal (Merck (DE) 202110 Senior Manager News + Media Relations) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
Gin, Gregory (Affimed 201808 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |